Variant position: 523 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 689 The length of the canonical sequence.
Location on the sequence:
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human EVEGKGRNAKNWKRNIRCEG MTLGE--------------------------------------------LLKRKNSDECEVCCQG
Mouse LNEGGRATSKDWKGVIRCNG ETLRH----------------
Rat LKKGGKATSKDWKKAIRCNK KTLRS----------------
Baker's yeast LQESKEKYKRELQKVITAND RLRREKEELNENSNNIRIMED
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
1 – 689 Sp110 nuclear body protein
454 – 535 SAND
Sp110 localizes to the PML-Sp100 nuclear body and may function as a nuclear hormone receptor transcriptional coactivator.
Bloch D.B.; Nakajima A.; Gulick T.; Chiche J.-D.; Orth D.; de La Monte S.M.; Bloch K.D.;
Mol. Cell. Biol. 20:6138-6146(2000)
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 3); SUBCELLULAR LOCATION; VARIANTS ARG-299 AND THR-523;
Variants in the SP110 gene are associated with genetic susceptibility to tuberculosis in West Africa.
Tosh K.; Campbell S.J.; Fielding K.; Sillah J.; Bah B.; Gustafson P.; Manneh K.; Lisse I.; Sirugo G.; Bennett S.; Aaby P.; McAdam K.P.W.J.; Bah-Sow O.; Lienhardt C.; Kramnik I.; Hill A.V.S.;
Proc. Natl. Acad. Sci. U.S.A. 103:10364-10368(2006)
Cited for: VARIANTS ARG-112; LYS-207; GLY-212; VAL-249; GLY-267; ARG-299; SER-425; THR-523 AND ILE-579;
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.